Details

Last Funding Type

Post-IPO Equity

Last Funding Money Raised

$250M

Industries

Biotechnology,Chemical,Health Care,Life Science

Founded date

Jan 1, 2013

Number Of Employee

501 - 1000

Operating Status

Active

Stock Symbol

nasdaq:TWST

Legal Name

Twist Bioscience Corporation

Also Known As

Twist

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development. At Twist Bioscience Corporation, they work in the service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, their customers are developing ways to better lives and improve the sustainability of the planet. They believe that the faster their customers succeed, the better for all of them, and Twist Bioscience is uniquely positioned to help accelerate their efforts.

Their innovative silicon-based DNA Synthesis Platform provides precision at a scale that we believe is otherwise unavailable to their customers. their platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead.

Twist Bioscience was founded in 2013 and is headquartered in San Francisco, California.

Twist Bioscience has acquired 3 organizations. Their most recent acquisition was Genome Compiler on Apr 6, 2016. They acquired Genome Compiler for 0.

Date Company Name	Industry	Acquisition Type	Price
Apr 6, 2016 Genome Compiler	Biotechnology	acquisition	—	Detail
Jun 30, 2021 iGenomX	Biotechnology	acquisition	$ 35M	Detail
Nov 22, 2021 Abveris	Biopharma	acquisition	$ 190M	Detail